Sacituzumab |
カタログ番号GC65538 |
サシツズマブは、抗栄養膜細胞表面抗原 2 (anti-Trop-2) に対するヒト化 IgG1 モノクローナル抗体です。サシツズマブには、転移性トリプルネガティブ乳がん研究の可能性があります。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1796566-95-4
Sample solution is provided at 25 µL, 10mM.
Trastuzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research[1].
[1]. A Bardia, et al. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Ann Oncol. 2021 Sep;32(9):1148-1156.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *